NCT06807164 2026-03-17
SerCaBot
Centre Oscar Lambret
Phase 2 Recruiting
Clinical Trials
7 trialsNCT04965311 2025-05-13
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT06530524 2024-07-31
Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Not yet recruiting
NCT02965976 2023-02-16
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT01822210 2018-03-09
Botulinum Toxin for Stomach Cancer Treatment
St. Olavs Hospital
Phase 2 Completed
NCT01589471 2018-02-12
The Value of Botox-A for Management of Low Anterior Resection Syndrome
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Completed
NCT00681148 2013-11-21
Botulinum Toxin Injection With Prostate Brachytherapy
Emory University
Phase 2 Withdrawn